Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial. (2013)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/1745-6215-14-10
PubMed Identifier: 23302220
Publication URI: http://europepmc.org/abstract/MED/23302220
Type: Journal Article/Review
Volume: 14
Parent Publication: Trials
ISSN: 1745-6215